- ►diabetesjournals.org J Buteau, S Foisy, E Joly, M Prentki - Diabetes, 2003 - Am Diabetes Assoc We previously provided evidence that glucagon-like peptide 1 (GLP-1) induces
pancreatic ß-cell growth nonadditively with glucose in a phosphatidylinositol
(PI) 3-kinase- and protein kinase C -dependent manner. However, the exact ... Cited by 147 - Related articles - BL Direct - All 5 versions
J Buteau, S Foisy, CJ Rhodes, L Carpenter, TJ … - Diabetes, 2001 - Am Diabetes Assoc Glucagon-like peptide-1 (GLP-1), an insulinotropic and glucoincretin hormone, is
a potentially important therapeutic agent in the treatment of diabetes. We
previously provided evidence that GLP-1 induces pancreatic β-cell growth ... Cited by 138 - Related articles - BL Direct - All 4 versions
J Buteau, R Roduit, S Susini, M Prentki - Diabetologia, 1999 - Springer Glucagon-like peptide-1-(7±36)amide (GLP-1) is se- creted by the
enteroendocrine L-cells in response to fat meals and carbohydrates [1, 2]. It is
a potent glu- coincretin hormone which acts as a competence fac- tor in ... Cited by 236 - Related articles - BL Direct - All 4 versions
Y Li, T Hansotia, B Yusta, F Ris, PA Halban, … - Journal of Biological Chemistry, 2003 - ASBMB Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion and augments β
cell mass via activation of β cell proliferation and islet neogenesis. We
examined whether GLP-1 receptor signaling modifies the cellular ... Cited by 254 - Related articles - BL Direct - All 7 versions
J Zhou, MA Pineyro, X Wang, ME Doyle, JM … - Journal of cellular physiology, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 63 - Related articles - BL Direct - All 3 versions
- ►endojournals.org H Hui, A Nourparvar, X Zhao, R Perfetti - Endocrinology, 2003 - Endocrine Soc The activation of the glucagon-like peptide-1 (GLP-1) receptor has been shown to
have an important role in the functional activity of islet ß-cells and in the
expansion of the islet cell mass. Constant remodeling of islet cell mass is ... Cited by 145 - Related articles - BL Direct - All 4 versions
- ►jbc.org PE MacDonald, X Wang, F Xia, W El-kholy, … - Journal of Biological Chemistry, 2003 - ASBMB Antagonism of voltage-dependent K + (Kv) currents in pancreatic -cells may
contribute to the ability of glucagon-like peptide-1 (GLP-1) to stimulate
insulin secretion. The mechanism and signaling pathway regulating these ... Cited by 30 - Related articles - BL Direct - All 4 versions
J Buteau, W El-Assaad, CJ Rhodes, L … - Diabetologia, 2004 - Springer Aims/hypothesis. We have provided evidence that gluca- gon-like peptide-1, a
potential therapeutic agent in the treatment of diabetes, activates
phosphatidylinositol-3 kinase/protein kinase B signalling in the pancreatic ... Cited by 113 - Related articles - BL Direct - All 4 versions
- ►endojournals.org L Farilla, H Hui, C Bertolotto, E Kang, A Bulotta … - Endocrinology, 2002 - Endocrine Soc A constant remodeling of islet cell mass mediated by proliferative and apoptotic
stimuli ensures a dynamic response to a changing demand for insulin. In this
study, we investigated the effect of glucagon-like peptide-1 (GLP-1) in ... Cited by 193 - Related articles - BL Direct - All 6 versions
J Buteau, ML Spatz, D Accili - Diabetes, 2006 - Am Diabetes Assoc The glucoincretin hormone glucagon-like peptide-1 (GLP-1) increases pancreatic
β-cell proliferation and survival through sequential activation of the
epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI ... Cited by 49 - Related articles - BL Direct - All 4 versions
